FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2963093289> ?p ?o ?g. }

• W2963093289 endingPage "1103" @default.
• W2963093289 startingPage "1097" @default.
• W2963093289 abstract "Abstract Purpose The use of buprenorphine, methadone, and long-acting naltrexone for treatment of opioid use disorder (OUD) is discussed, including a review of current literature detailing treatment approaches and action steps to optimize treatment in acute care and office-based settings. Summary The U.S. epidemic of opioid-related deaths has been driven by misuse of prescription opioids and, increasingly, illicit drugs such as heroin, fentanyl, and fentanyl analogs, necessitating a refocusing of treatment efforts on expanding access to life-saving, evidence-based OUD pharmacotherapy. Inpatient treatment of opioid withdrawal includes acute symptom control through a combination of nonopioid medications and long-term pharmacotherapy to lessen opioid craving and facilitate stabilization and recovery. Methadone and buprenorphine reduce opioid craving, increase treatment retention, reduce illicit opioid use, and increase overall survival. Buprenorphine has logistical advantages over methadone, such as greater flexibility of treatment setting and less risk of adverse effects. Studies have shown the efficacy of long-acting injectable naltrexone to be comparable to that of buprenorphine if patients are detoxified prior to initiation of therapy; however, patients with active OUD are often not able to complete the week-long period of opioid abstinence needed prior to initiation of naltrexone injections. Although buprenorphine is preferred by many patients and can be prescribed in office-based settings, there remains a paucity of physicians certified to prescribe it. Conclusion Buprenorphine has become the medication of choice for many patients with OUD, but its use is limited by the low number of physicians certified to prescribe the agent. Other agents studied for treatment of OUD include methadone and naltrexone." @default.
• W2963093289 created "2019-07-30" @default.
• W2963093289 creator A5005271985 @default.
• W2963093289 creator A5011226315 @default.
• W2963093289 creator A5059333533 @default.
• W2963093289 date "2019-07-18" @default.
• W2963093289 modified "2023-10-14" @default.
• W2963093289 title "Medications for management of opioid use disorder" @default.
• W2963093289 cites W1529433275 @default.
• W2963093289 cites W1533300735 @default.
• W2963093289 cites W1541544646 @default.
• W2963093289 cites W1979097034 @default.
• W2963093289 cites W1995098257 @default.
• W2963093289 cites W1998034548 @default.
• W2963093289 cites W2000740780 @default.
• W2963093289 cites W2018914766 @default.
• W2963093289 cites W2027635335 @default.
• W2963093289 cites W2041970939 @default.
• W2963093289 cites W2050794236 @default.
• W2963093289 cites W2070677288 @default.
• W2963093289 cites W2076355639 @default.
• W2963093289 cites W2097910464 @default.
• W2963093289 cites W2109770916 @default.
• W2963093289 cites W2115919908 @default.
• W2963093289 cites W2152506996 @default.
• W2963093289 cites W2158292788 @default.
• W2963093289 cites W2167911929 @default.
• W2963093289 cites W2464809120 @default.
• W2963093289 cites W2552987856 @default.
• W2963093289 cites W2606264631 @default.
• W2963093289 cites W2768214444 @default.
• W2963093289 cites W2791412728 @default.
• W2963093289 cites W2792664586 @default.
• W2963093289 cites W2896249325 @default.
• W2963093289 cites W2898879786 @default.
• W2963093289 cites W2906591149 @default.
• W2963093289 doi "https://doi.org/10.1093/ajhp/zxz105" @default.
• W2963093289 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31361869" @default.
• W2963093289 hasPublicationYear "2019" @default.
• W2963093289 type Work @default.
• W2963093289 sameAs 2963093289 @default.
• W2963093289 citedByCount "49" @default.
• W2963093289 countsByYear W29630932892020 @default.
• W2963093289 countsByYear W29630932892021 @default.
• W2963093289 countsByYear W29630932892022 @default.
• W2963093289 countsByYear W29630932892023 @default.
• W2963093289 crossrefType "journal-article" @default.
• W2963093289 hasAuthorship W2963093289A5005271985 @default.
• W2963093289 hasAuthorship W2963093289A5011226315 @default.
• W2963093289 hasAuthorship W2963093289A5059333533 @default.
• W2963093289 hasConcept C118552586 @default.
• W2963093289 hasConcept C126322002 @default.
• W2963093289 hasConcept C170493617 @default.
• W2963093289 hasConcept C177713679 @default.
• W2963093289 hasConcept C2426938 @default.
• W2963093289 hasConcept C2776029756 @default.
• W2963093289 hasConcept C2777972943 @default.
• W2963093289 hasConcept C2778767360 @default.
• W2963093289 hasConcept C2778903686 @default.
• W2963093289 hasConcept C2778949969 @default.
• W2963093289 hasConcept C2779158186 @default.
• W2963093289 hasConcept C2779418921 @default.
• W2963093289 hasConcept C2779541405 @default.
• W2963093289 hasConcept C2780035454 @default.
• W2963093289 hasConcept C2781063702 @default.
• W2963093289 hasConcept C2781072394 @default.
• W2963093289 hasConcept C42219234 @default.
• W2963093289 hasConcept C48856860 @default.
• W2963093289 hasConcept C500440147 @default.
• W2963093289 hasConcept C71924100 @default.
• W2963093289 hasConcept C98274493 @default.
• W2963093289 hasConceptScore W2963093289C118552586 @default.
• W2963093289 hasConceptScore W2963093289C126322002 @default.
• W2963093289 hasConceptScore W2963093289C170493617 @default.
• W2963093289 hasConceptScore W2963093289C177713679 @default.
• W2963093289 hasConceptScore W2963093289C2426938 @default.
• W2963093289 hasConceptScore W2963093289C2776029756 @default.
• W2963093289 hasConceptScore W2963093289C2777972943 @default.
• W2963093289 hasConceptScore W2963093289C2778767360 @default.
• W2963093289 hasConceptScore W2963093289C2778903686 @default.
• W2963093289 hasConceptScore W2963093289C2778949969 @default.
• W2963093289 hasConceptScore W2963093289C2779158186 @default.
• W2963093289 hasConceptScore W2963093289C2779418921 @default.
• W2963093289 hasConceptScore W2963093289C2779541405 @default.
• W2963093289 hasConceptScore W2963093289C2780035454 @default.
• W2963093289 hasConceptScore W2963093289C2781063702 @default.
• W2963093289 hasConceptScore W2963093289C2781072394 @default.
• W2963093289 hasConceptScore W2963093289C42219234 @default.
• W2963093289 hasConceptScore W2963093289C48856860 @default.
• W2963093289 hasConceptScore W2963093289C500440147 @default.
• W2963093289 hasConceptScore W2963093289C71924100 @default.
• W2963093289 hasConceptScore W2963093289C98274493 @default.
• W2963093289 hasIssue "15" @default.
• W2963093289 hasLocation W29630932891 @default.
• W2963093289 hasLocation W29630932892 @default.
• W2963093289 hasOpenAccess W2963093289 @default.
• W2963093289 hasPrimaryLocation W29630932891 @default.
• W2963093289 hasRelatedWork W1922363525 @default.

• next